Potential use of biodegradable nanoparticles for the photodynamic therapy of eye diseases.
Vargas
A
A
Delie
F
F
D000818:Animals; D001711:Biotransformation; D002642:Chick Embryo; D049033:Chorioallantoic Membrane / Q000098:blood supply; D020256:Choroidal Neovascularization / Q000188:drug therapy; D003102:Colloids; D004339:Drug Compounding / Q000379:methods; D004353:Drug Evaluation, Preclinical; D005134:Eye Neoplasms / Q000098:blood supply / Q000188:drug therapy; D006801:Humans; D019344:Lactic Acid; D053758:Nanoparticles / Q000008:administration & dosage*; D009389:Neovascularization, Pathologic / Q000188:drug therapy*; D010778:Photochemotherapy / Q000379:methods*; D017319:Photosensitizing Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000627:therapeutic use; D011100:Polyglycolic Acid; D000077182:Polylactic Acid-Polyglycolic Acid Copolymer; D011166:Porphyrins / Q000008:administration & dosage / Q000493:pharmacokinetics; D015861:Retinal Neovascularization / Q000188:drug therapy
D003102:Colloids; D017319:Photosensitizing Agents; D011166:Porphyrins; C018395:tetracarboxyphenylporphine; D000077182:Polylactic Acid-Polyglycolic Acid Copolymer; D011100:Polyglycolic Acid; D019344:Lactic Acid